imiquimod has been researched along with orabase in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Cunningham, LL; Dziubla, TD; Puleo, DA; Ramineni, SK | 1 |
Corcoran, LM; Lyons, AB; Patchett, AL; Tovar, C; Woods, GM | 1 |
Baz Morelli, A; Belov, K; Carver, S; Corcoran, LM; Fox, S; Hogg, CJ; Kreiss, A; Lyons, AB; McLennan, E; Patchett, A; Pearse, MJ; Pemberton, D; Pye, R; Silva, A; Thomson, R; Woods, GM | 1 |
Borrego-Luque, A; Manzotti, C; Rollón-Mayordomo, Á; Ruiz-Huertas, P; Toledano-Valero, P | 1 |
4 other study(ies) available for imiquimod and orabase
Article | Year |
---|---|
Local delivery of imiquimod in hamsters using mucoadhesive films and their residence time in human patients.
Topics: Administration, Buccal; Adult; Aminoquinolines; Animals; Antineoplastic Agents; Carboxymethylcellulose Sodium; Chromatography, High Pressure Liquid; Cricetinae; Drug Delivery Systems; Female; Humans; Imiquimod; Male; Middle Aged; Mouth Mucosa; Pilot Projects; Povidone | 2014 |
The toll-like receptor ligands Hiltonol
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antigens; Cancer Vaccines; Carboxymethylcellulose Sodium; Cells, Cultured; Facial Neoplasms; Hemocyanins; Humans; Imiquimod; Immunity; Immunity, Innate; Immunization; Immunoglobulin G; Leukocytes, Mononuclear; Lymphocyte Activation; Marsupialia; Poly I-C; Polylysine; Toll-Like Receptors | 2017 |
Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release.
Topics: Adjuvants, Immunologic; Animals; Cancer Vaccines; Carboxymethylcellulose Sodium; Facial Neoplasms; Female; Histocompatibility Antigens Class I; Imiquimod; Immunity, Humoral; Immunization, Secondary; Immunoglobulin G; Immunotherapy; Male; Marsupialia; Poly I-C; Polylysine; Tumor Escape | 2018 |
Oral florid papillomatosis: Topical treatment with 5% imiquimod in orabase.
Topics: Administration, Topical; Aged; Carboxymethylcellulose Sodium; Female; Humans; Imiquimod; Papilloma | 2022 |